Lung microbiome is associated with asthma severity in fungal associated asthma Source: International Congress 2015 – Phenotyping asthma with biomarkers Year: 2015
IL-17A in severe asthma, severe asthma with fungal sensitisation and ABPA Source: International Congress 2015 – Phenotyping asthma with biomarkers Year: 2015
Induced sputum in children With persistent asthma: The effect to inhaled corticosteroid treatment Source: Annual Congress 2013 –Monitoring asthma: genes, cells and molecules Year: 2013
Pulmonary and systemic inflammation in patients with AECOPD Source: Annual Congress 2013 –COPD: new markers of diseases Year: 2013
Small airways targeting of inhaled steroids for severe therapy resistant asthma in children Source: International Congress 2015 – Paediatric asthma and allergy: asthma management Year: 2015
Induced sputum in children with persistent asthma: the effect of inhaled corticosteroid treatment Source: Eur Respir J 2006; 28: Suppl. 50, 258s Year: 2006
Wet cough in paediatric severe therapy resistant asthma (STRA) Source: International Congress 2016 – Paediatric asthma: recurrent, persistent, or severe obstruction and lung function techniques Year: 2016
Study of some inflammatory markers in children with moderate persistent bronchial asthma before and after therapy with inhaled corticosteroids Source: Annual Congress 2013 –Monitoring asthma: genes, cells and molecules Year: 2013
Targeting PI3KΔ or JAK in T-cells from COPD and severe asthma subjects reduces corticosteroid insensitive inflammatory responses Source: Annual Congress 2013 –COPD: new markers of diseases Year: 2013
Duration of inhaled corticosteroid therapy in children with asthma and frequency of community-acquired pneumonia in them Source: International Congress 2016 – Drugs, bugs, BMI, and other problems in paediatric asthma Year: 2016
Induced sputum in children with mild-moderate persistent asthma: the effect of inhaled corticosteroid treatment Source: Annual Congress 2008 - Assessment of inflammation, hyperresponsiveness and response to exercise in asthmatic children Year: 2008
Stable COPD: predicting benefit from high-dose inhaled corticosteroid treatment Source: Eur Respir J 2006; 27: 964-971 Year: 2006
Activation of MMP-9 in BAL is increased in COPD exacerbation independently of smoking, lung function, microbiology and treatment Source: International Congress 2014 – New studies into pulmonary proteases and antiproteases Year: 2014
Influence of basic therapy of bronchial asthma (BA) on respiratory symptoms in patients with pulmonary TB associated with bronchial asthma Source: International Congress 2014 – Tuberculosis: from epidemiology to therapy 1 Year: 2014
Are there differences in the bronchoalveolar lavage (BAL) cytokine profile in children with and without allergic asthma? Source: International Congress 2014 – More paediatric asthma Year: 2014
LATE-BREAKING ABSTRACT: Long-term effects of inhaled corticosteroids on sputum bacterial and viral loads in COPD patients Source: International Congress 2015 – Infection in COPD: different aspects of the host/pathogen balance Year: 2015
Changes in symptoms, respiratory function, airway inflammation, and airway hyperresponsiveness over 10 year of inhaled corticosteroid therapy in adult asthma patients Source: International Congress 2015 – New data on established treatments for asthma and COPD Year: 2015
Acute exacerbations in COPD patients are associated with increased levels of hyaluronic acid and heparan sulfate in BAL Source: International Congress 2014 – Translational studies in COPD Year: 2014
Refractory severe asthma: Is presence of aspergillus in broncho-alveolar lavage significant? Source: International Congress 2015 – Respiratory infections: from basic science to clinical issues Year: 2015